Summary: Accenture's stock is outperforming the S&P 500 over the last year. Additionally, the stock is outperforming the broader market over the last 1-,3- and 5-year periods. Shares are currently richly valued, but I believe that the company's growth potential is not fully baked into the stock price. We hold a position in Accenture, and we plan to add shares on pullbacks. Accenture's (ACN) stock has performed well over the last year, as ACN shares have outperformed the broad

Summary: MetLife's stock has significantly outperformed the broader market over the last year, and the company's most recent operating results helped the bull case. Moreover, it appears that this insurer is well-positioned for 2021 and beyond. We are long MetLife, and we plan to stay long the stock. Read more here.

Summary: Charles River's stock has significantly outperformed the S&P 500 over the last 1-,3- and 5-year periods. Better yet, Charles River is well-positioned for 2021 and beyond, as I believe the future for this company looks even brighter the further you are willing to look out. Long-term shareholders should consider sticking with what has been working because, in my opinion, CRL shares should continue to outperform the broader market over the next 18-24 months. Read more h